1cP-LSD Micro Blotters 20mcg lysergamide research material from Raw Lab Chems
Buy 1cP-LSD Micro Blotters - 20mcg Price range: € 31,25 through € 95,00
Back to products
1cP-LSD Micro Pellets
1cP-LSD Micro Pellets - 10mcg Price range: € 10,00 through € 100,00

Buy 1cP-LSD Pellets – 150mcg

Price range: € 33,45 through € 440,00

1cP-LSD Pellets are described as compressed research units associated with 1-cyclopropanoyl-LSD, an N1-acylated derivative of lysergic acid diethylamide.

The named compound belongs to the lysergamide family and is distinguished from LSD by the addition of a cyclopropanecarbonyl substituent at the indole nitrogen.

The supplied source describes a pellet-format material with a labeled analyte quantity, intended for controlled analytical and reference-oriented laboratory research.

Relevant scientific contexts include chemical identification, chromatographic method development, lysergamide structural characterization, and analytical comparison of related compounds.

The source reports CAS number 2767597-50-0, molecular formula C₂₄H₂₉N₃O₂, and an approximate molecular weight of 391.51 g/mol.

However, the actual chemical form, ingredient purity, excipient composition, finished-unit analyte content, and content uniformity have not been independently verified.

Claims concerning analytical testing, certified reference-material status, and batch documentation remain unsubstantiated without actual supporting records.

For research use only. Not for human or veterinary use. Not for clinical, diagnostic, or consumptive applications.

SKU: CERT-P-12938 Category:
Description

1cP-LSD Pellets 150mcg – Lysergamide Research Material

Product Overview

1cP-LSD Pellets are described as compressed research units associated with 1-cyclopropanoyl-LSD, an acylated derivative of lysergic acid diethylamide.

The named compound belongs to the lysergamide family.

Its molecular structure differs from LSD through the presence of a cyclopropanecarbonyl substituent at the indole nitrogen.

The supplied source presents the product as a pellet-format preparation intended for controlled analytical and scientific research.

The source identifies a labeled analyte quantity per pellet.

However, no actual finished-unit assay or content-uniformity report accompanied the information.

The labeled analyte quantity therefore remains a source-provided specification rather than an independently verified result.

The supplied material also describes analytical investigation of lysergamide structure, chemical identity, and relationships among N1-acylated derivatives.

These scientific contexts should be distinguished from claims about the performance of the actual finished pellets.

No batch-specific analytical identity certificate, impurity profile, or validated assay result was provided.

The source makes additional claims concerning purity, standardized pellet content, laboratory verification, and certified reference-material status.

These claims remain unverified without supporting documentation.

The finished preparation is not established as a certified reference material, validated quantitative calibrator, or approved pharmaceutical product.

Chemical Identity & Classification

The supplied source identifies 1cP-LSD as 1-cyclopropanoyl-LSD, an N1-acylated lysergamide.

The cyclopropanoyl substituent distinguishes it structurally from LSD and other acylated lysergamides.

The supplied chemical information includes:

  • Common designation: 1cP-LSD
  • Descriptive name: 1-Cyclopropanoyl-LSD
  • Alternative designation: 1-CPA-LSD
  • Reported CAS Registry Number: 2767597-50-0
  • Reported molecular formula: C₂₄H₂₉N₃O₂
  • Reported molecular weight: 391.51 g/mol
  • Chemical classification: N1-acylated lysergamide
  • Reported presentation: Compressed pellets
  • Labeled analyte amount: Specified per finished pellet
  • Intended designation: Research Use Only

The supplied source also provides a systematic chemical name and SMILES notation incorporating stereochemical information.

However, no batch-specific structural or stereochemical verification report was provided.

The reported molecular formula and molecular weight are arithmetically consistent.

This consistency does not independently establish the identity or stereochemical composition of the actual product.

The source does not establish whether the finished pellets contain a free-base form, a particular salt, or other formulation components.

These distinctions are relevant when interpreting molecular-weight calculations and analytical measurements.

Researchers may consult PubChem for public chemical-reference information, ensuring that the selected database entry corresponds to the actual molecular structure and stereochemical designation being examined.

Chemical & Physical Characteristics

The supplied source describes the product as compressed pellets containing a labeled quantity of 1cP-LSD.

A pellet is a finished preparation in which the named analyte may be combined with additional formulation components.

The characteristics of the complete preparation therefore differ from those of the isolated chemical compound.

The source does not identify the excipient composition, dimensions, total unit mass, or manufacturing method.

No actual product-specific inspection report or finished-unit composition record was supplied.

The named compound contains an N1-cyclopropanoyl substituent attached to the lysergamide framework.

This structural feature distinguishes 1cP-LSD from LSD and from other lysergamide derivatives containing different substituents.

However, structural classification alone does not establish the physicochemical characteristics of the actual pellet preparation.

The source does not provide experimentally verified solubility measurements, degradation profiles, or complete physical characterization.

It also does not establish the distribution of analyte throughout the compressed formulation.

Consequently, the properties of the isolated compound should not be assumed to describe the complete finished unit.

The source recommends dry, dark storage and identifies low-temperature storage as appropriate for extended preservation.

No validated product-specific stability study accompanied those recommendations.

Purity & Analytical Verification

The supplied source claims a minimum ingredient purity of 98%.

However, no actual batch-specific Certificate of Analysis or laboratory report accompanied that statement.

The claimed purity therefore remains a supplier-provided specification rather than an independently verified result.

The source refers to HPLC, LC-MS, and NMR spectroscopy as analytical verification methods.

No chromatogram, spectrum, impurity profile, or independent laboratory certificate was supplied.

Accordingly, no particular purity result can be confirmed for the actual product batch.

For pellet preparations, the chemical purity of the named ingredient and the actual analyte quantity in each finished unit are separate analytical characteristics.

An ingredient-purity result does not independently establish finished-unit content or content uniformity.

The source refers to analytical findings from other pellet samples involving a hemitartrate form and corresponding free-base equivalence.

Those findings cannot be generalized to the actual product without evidence that the tested samples and the current batch share the same chemical form and formulation specifications.

The source also claims ISO/IEC 17025 and ISO 17034 certification where applicable.

No accreditation record, certification scope, or certified reference-material documentation was supplied.

The finished pellets should therefore not be represented as certified quantitative reference standards.

Quality Control & Batch Integrity

The supplied source describes quality-control practices, batch documentation, and analytical verification.

It also claims that Certificates of Analysis are provided with orders.

No actual certificate, independent testing report, manufacturing audit, or batch-specific quality-control record accompanied the information.

These statements therefore remain unverified supplier claims.

For reproducible analytical documentation, relevant records may include verified chemical identifiers, confirmed stereochemical composition where available, batch number, analytical findings, receipt date, and available storage history.

For pellet preparations, the identity and purity of the named compound should be distinguished from the composition and consistency of the finished units.

The supplied information does not establish independently verified analyte content, excipient composition, or content uniformity.

The source also does not provide evidence that every finished pellet meets a particular quantitative specification.

The Research Use Only designation describes intended positioning but does not independently demonstrate manufacturing quality or analytical traceability.

Claims concerning batch consistency and validated analytical performance should be supported by actual records.

Safety, Handling & Laboratory Precautions

1cP-LSD is a synthetic lysergamide associated with significant pharmacological activity and potential toxicological uncertainty.

The supplied source discusses possible metabolic conversion to LSD.

However, the actual product was not accompanied by a batch-specific biological activity or toxicological assessment.  1cP-LSD Pellets

Laboratory personnel should consult applicable chemical-safety documentation and institutional procedures before receiving or examining the material.

Relevant precautions include restricted access, appropriate protective equipment, contamination prevention, accidental-exposure procedures, and chemical-waste management.

The pellet presentation does not establish safety for human or veterinary exposure.

The material should remain secured against unauthorized access and separated from food, beverages, and non-research environments.

The supplied source contains animal behavioral findings and potency comparisons.

These findings should not be interpreted as evidence of the actual finished pellets’ quantitative content or suitability for any human application.

Any accidental exposure or contamination incident should be managed according to institutional emergency procedures.

Packaging, Labeling & Storage

The supplied source describes double-sealed packaging, protective handling, and specialized shipment arrangements.

No actual packaging specification, container-validation report, or shipment-condition record was provided.    1cP-LSD Pellets

The source recommends storage in a dry, dark environment and refers to approximately −20°C for extended storage.

No validated product-specific stability study was supplied to establish that temperature as a verified requirement or to support a particular shelf life.

The source also suggests that specialized temperature-controlled shipping may be required.

No supporting shipment-stability study accompanied that claim.

Laboratory inventory records should preserve the product designation, any available batch identifier, receipt details, and relevant storage observations.

The labeled analyte quantity should be recorded as a source-provided specification unless independently verified.

Packaging and environmental requirements should be assessed using available safety documentation, relevant stability evidence, and institutional procedures.

Intended Research Use & Market Positioning

The supplied scientific context places 1cP-LSD within analytical research involving lysergamide chemical identity, N1-acyl substitution, and relationships among structurally related compounds.

The cyclopropanoyl substituent provides a distinguishing structural feature relevant to chemical characterization.

The source also describes scientific interest in the relationship between 1cP-LSD and LSD.

However, no product-specific metabolic, receptor-binding, or pharmacological dataset was supplied for the actual pellets.  1cP-LSD Pellets

The supplied Raw Lab Chems catalog includes 1cP-LSD Pellets, corresponding to the listing discussed here.

For comparative product-format context, Raw Lab Chems also lists 1cP-LSD Micro Pellets and 1D-LSD Blotters.

The micro-pellet listing refers to the same named compound with a different labeled strength.

The 1D-LSD listing refers to a structurally related but chemically distinct lysergamide.

These products should not be treated as chemically identical or analytically interchangeable.

The supplied information does not establish equivalent chemical purity, analyte content, excipient composition, or content uniformity across the preparations.

These catalog references should not be interpreted as evidence of certified reference-material status or validated quantitative equivalence.

Ordering, Availability & Fulfillment

The supplied source describes protective packaging, international shipping, tracking, and expedited delivery arrangements.  1cP-LSD Pellets

No current inventory record, carrier agreement, shipment authorization, or verified delivery information was supplied.

Consequently, no availability, delivery-time, customs-clearance, or transportation-compliance guarantee is asserted.

1cP-LSD may be subject to controlled-substance, analogue, pharmaceutical, or other chemical regulations depending on the jurisdiction.

Institutional acquisition, possession, transportation, importation, and exportation must be assessed under applicable laws.

Research-only labeling does not establish a legal exemption.

Legal & Regulatory Disclaimer

For research use only. Not for human or veterinary use. Not for clinical, diagnostic, or consumptive applications.

1cP-LSD is a synthetic lysergamide whose possession, acquisition, transfer, transportation, importation, exportation, and laboratory investigation may be restricted or prohibited depending on the jurisdiction.  1cP-LSD Pellets

The supplied information does not establish universal legal status or regulatory authorization.

Institutions remain responsible for determining applicable legal requirements and obtaining any necessary permissions.

No medical approval, consumer-use authorization, or regulatory exemption is implied by this description.

Additional information
Quantity (pellets)

5

,

10

,

25

,

50

,

100

Reviews (0)

Reviews

There are no reviews yet.

Be the first to review “Buy 1cP-LSD Pellets – 150mcg”
Shipping & Delivery